AzTrials
AzTrials

StrokeNCT01776034

Health Promotion and Wellness Program for Adults With Disabling Conditions

A study testing SystemCHANGE Group Lifestyle counseling and Phone Lifestyle Counseling in people with Stroke and Multiple Sclerosis, run by Case Western Reserve University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to conduct a randomized controlled pilot study to examine the efficacy, feasibility and safety of the SystemCHANGE™(SC) health promotion and wellness program in adults with disabling conditions. Read more about this study

Who is it for?
Ages 30 to 75 years
Conditions the study is for
Stroke, Multiple Sclerosis, Rheumatoid Arthritis
What is being tested?
SystemCHANGE Group Lifestyle counseling and Phone Lifestyle Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteUnited States
Study dates
Jan 2013to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Physician-confirmed diagnosis of stroke (> 6 weeks)
  • Body mass index between 23 to 45 kg/m2
  • Age 30 to 75 years
  • Physician-confirmed diagnosis of multiple sclerosis or rheumatoid arthritis
  • Body mass index between 23 to 45 kg/m2

Who cannot join

  • Pregnant or plans to become pregnant in the next 6 months
  • Current participation in a face-to-face weight management program
  • Uncontrolled diabetes (hospitalization within the prior 6 months)
  • Serious mental illness
  • Thyroid and adrenal gland diseases
  • Inability to walk 3 meters with or without a cane or walker
Show all 26Show fewer
  • Severe cardiopulmonary disease that limits engagement in physical activity (e.g., myocardial infarction, congestive heart failure, coronary artery bypass grafting or valve replacement during the past three months, serious cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, and pulmonary embolus) or abnormal blood pressure or heart rate response after the 6-Minute Walking Test (e.g., a drop in systolic blood pressure of >10mmHg from baseline)
  • Severe cognitive deficits (Screening questioanire called the Short Orientation Memory-Concentration < 12)
  • Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
  • 3 or more falls in the past month
  • Bulimia
  • Unable to speak English over the phone
  • Able to eat independently and is not on a special diet because of difficulty in swallowing
  • Unstable weight (gained or lost >10lbs in the last two months)
  • Pregnant or plans to become pregnant in the next 6 months
  • Current participation in a face-to-face weight management program
  • Uncontrolled diabetes (hospitalization within the prior 6 months)
  • Serious mental illness
  • Inability to walk 3 meters with or without a cane or walker
  • Severe cardiopulmonary disease that limits engagement in physical activity
  • Severe cognitive deficits (Short Orientation Memory-Concentration < 12)
  • Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
  • 3 or more falls in the past month
  • Bulimia
  • Unable to speak English
  • Uncontrolled thyroid or adrenal disease (change in type and dosage of medication within the prior 3 months)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Case Western Reserve University

    Cleveland, Ohio, 44106

Other trials in United States

About this study

Official title: Examining the Efficacy of a SystemCHANGE™ Weight Management Intervention in Stroke Survivors and Persons With Chronic Inflammatory Autoimmune/Immune-mediated Diseases

The objective of this study is to conduct a randomized controlled pilot study to examine the efficacy, feasibility and safety of the SystemCHANGE™(SC) health promotion and wellness program in adults with disabling conditions. Particularly, the study will focus on developing a program of research on adapting and testing SC weight management interventions in overweight and obese stroke survivors and persons with chronic inflammatory autoimmune/immune-mediated diseases, specifically those with multiple sclerosis (MS) and rheumatoid arthritis (RA).

Read the detailed description

Individuals with disabling conditions, such as stroke, multiple sclerosis, or rheumatoid arthritis, face many barriers to engaging in physical activity, healthy nutritional habits, and good sleep hygiene. This leads to weight gain, de-conditioning, and declines in upper- and lower- extremity function, which makes it even more difficult to engage in healthy behaviors, thereby perpetuating a cycle of functional decline. Developing an effective weight management intervention may be a strategy for disrupting this disabling cycle and reducing the impact of the disease. Fostering a positive social environment may help adults with disabling conditions overcome barriers to engaging in healthy behaviors. SystemCHANGE (SC) is a new behavior change program that uses approaches consistent with social ecological theories and process improvement techniques (i.e. changing the dynamics of a system or group) to increase social support in lifestyle behaviors that promote energy balance. SC focuses on redesigning the social environment using a series of trial-and-error "experiments", which is in contrast to cognitive-behavioral interventions that focus on changing a person's viewpoint of a situation and increasing motivation. In a SC intervention, individuals are taught a set of skills to assist them in incorporating habitual lifestyle behaviors into their daily systems so they succeed despite wavering motivation. The rationale for developing a weight management intervention for these patients is to slow disability progression and prevent secondary conditions.

Being tested
SystemCHANGE Group Lifestyle counseling, Phone Lifestyle Counseling
Keywords
Self Care, Exercise, Weight management
Medical subject headings
Stroke, Multiple Sclerosis, Arthritis, Rheumatoid, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SystemCHANGE Group Lifestyle counselingBehavioural

  • Phone Lifestyle CounselingBehavioural

Study groups in NCT01776034
Study groupRoleWhat they receive
SystemCHANGE Group Lifestyle counselingExperimentalThe SystemCHANGE™ intervention will be delivered over a six-month period involving 12 face-to-face group sessions (1.5 to 2 hours each) held weekly for three months, followed by three monthly "booster calls." Intervention groups include ~10 to 15 patients, and friends and family members are encouraged to attend. Intervention sessions consist of 30-min to 60-min of behavior change activities and 60-min focused on healthy behaviors.
Receives: Behavioral: SystemCHANGE Group Lifestyle counseling
Phone Lifestyle CounselingActive comparatorParticipants will receive pamphlets that contain information on healthy eating, physical activity, sleep, and symptom management, and will be followed-up with telephone calls.
Receives: Behavioral: Phone Lifestyle Counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes from baseline in body weight.

    A digital scale will be used to measure Body weight.

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

Secondary outcomes (7)
  1. Changes from baseline in cardiovascular risk biomarkers.

    The Alere Cholestech LDX 1 Analyzer will be used to measure Triglycerides levels.

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

  2. Changes from baseline in Walking Test.

    A Six Minute Walking Test will be administered using standardized instructions and verbal cues

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

  3. Changes from baseline in 1-minute sit to stand test

    A 1-minute sit to stand test will be administered using standardized instructions and verbal cues

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

  4. Changes from baseline Physical Activity

    Physical Activity and Disability Survey-Revised will be administered to assess physical function. Higher scores on the Physical Activity and Disability Survey-Revised indicates increased physical activity levels. Score range: Not applicable.

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

  5. Changes from baseline Self-efficacy for weight management

    Weight Efficacy Lifestyle Questionnaire-Short Form (WEL-SF) will be administered. A higher score on the weight efficacy lifestyle questionnaire indicates more confidence to engage in a healthy behavior (possible score range for self-efficacy weight is 1 to 10)

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

  6. Changes from baseline social support for physical activity from family

    Social Support for Exercise Behavior scales will be administered. A higher score on social support scales indicates greater social support from family to engage in physical activity (possible score range is 1 to 5).

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

  7. Changes from baseline in emotional well-being

    Quality of Life in Neurological Disorders (Neuro-Qol) positive affect \& wellbeing questionnaires will be administered. Higher scores on Quality of Life in Neurological Disorders (Neuro-Qol) positive affect and well-being indicates a greater life satisfaction (possible score range 9 to 45).

    Measured: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01776034
Sponsor's protocol ID
07-14-16 / 03-14-24
Status last verified
Jan 2022
First submitted
23 Jan 2013
Last updated
24 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Plow M, Moore SM, Kirwan JP, Frost F, Katzan I, Jaeger S, Alberts J. Randomized controlled pilot study of a SystemCHANGE weight management intervention in stroke survivors: rationale and protocol. Trials. 2013 May 7;14:130. doi: 10.1186/1745-6215-14-130.

    PubMed 23782741

Questions about this trial

What is this clinical trial studying?

A study testing SystemCHANGE Group Lifestyle counseling and Phone Lifestyle Counseling in people with Stroke and Multiple Sclerosis, run by Case Western Reserve University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 26 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes from baseline in body weight. (time frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01776034, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in